A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Incyte Corporation
Actym Therapeutics, Inc.
Pfizer
University of Virginia
Turnstone Biologics, Corp.
Seagen Inc.
Sotio Biotech Inc.
Aminex Therapeutics, Inc.
Astellas Pharma Inc
Molecular Templates, Inc.
University of Florida
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
CureOne